{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:15:06Z","timestamp":1770894906709,"version":"3.50.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"LIAISON PLEX\u00ae"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate and timely identification of upper respiratory tract pathogens can improve patient management by decreasing unnecessary additional testing, reducing the cost of care, and informing antimicrobial stewardship. We evaluated the FDA-cleared Diasorin LIAISON PLEX\u00ae Respiratory Flex (RSP Flex), a highly multiplexed, rapid nucleic acid detection assay that can identify 14 viral and 5 bacterial respiratory pathogens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In total, 215 residual patient upper respiratory tract specimens were tested using the RSP Flex assay and results compared to standard-of-care (SOC) molecular testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Positive percentage agreement (PPA) was 100% for the following targets: adenovirus, human coronavirus, Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, and Chlamydia pneumoniae. Performance for the remaining panel targets were: human enterovirus\/rhinovirus PPA = 97.5% (39\/40), influenza A virus PPA = 92.3% (12\/13), human metapneumovirus PPA = 87.5% (14\/16), influenza B virus PPA = 92.9% (13\/14), parainfluenza 1 virus PPA = 85.7% (6\/7), parainfluenza 2 virus PPA = 80% (4\/5), parainfluenza 3 virus PPA = 85.7% (12\/14), parainfluenza 4 virus PPA = 87.5% (7\/8), respiratory syncytial virus (RSV) PPA = 92.9% (13\/14), and SARS-CoV-2 PPA = 95.0% (19\/20). The negative percentage agreement (NPA) for all targets was 100% except adenovirus NPA = 98.4% (180\/183), enterovirus\/rhinovirus NPA = 96.9% (155\/160), and M. pneumoniae NPA = 91.9% (34\/37). For all targets, the RSP Flex assay had an overall PPA of 93.8%, NPA of 99.5% and complete concordance of 99.1% compared to SOC testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The LIAISON PLEX RSP Flex assay is a fully automated, sample-to-customizable answer system that offers a wide range of bacterial and viral target testing with high accuracy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jalm\/jfaf144","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:50:29Z","timestamp":1756900229000},"page":"113-119","source":"Crossref","is-referenced-by-count":1,"title":["Performance of a Rapid, Highly Multiplexed Nucleic Acid Detection Assay for Identification of Viral and Bacterial Pathogens from Upper Respiratory Tract Specimens"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6916-6450","authenticated-orcid":false,"given":"Coreen L","family":"Johnson","sequence":"first","affiliation":[{"name":"Department of Pathology, Texas Children\u2019s Hospital , Houston, TX ,","place":["United States"]},{"name":"Department of Pathology & Immunology, Baylor College of Medicine , Houston, TX ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7964-281X","authenticated-orcid":false,"given":"James J","family":"Dunn","sequence":"additional","affiliation":[{"name":"Department of Pathology, Texas Children\u2019s Hospital , Houston, TX ,","place":["United States"]},{"name":"Department of Pathology & Immunology, Baylor College of Medicine , Houston, TX ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"2026021205170614200_jfaf144-B1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jhm.2624","article-title":"Epidemiology of pediatric hospitalizations at general hospitals and freestanding children\u2019s hospitals in the United States","volume":"11","author":"Leyenaar","year":"2016","journal-title":"J Hosp Med"},{"key":"2026021205170614200_jfaf144-B2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/antibiotics11081139","article-title":"Antimicrobial stewardship strategies including point-of-care testing (POCT) for pediatric patients with upper-respiratory-tract infections in primary care: a systematic review of economic evaluations","volume":"11","author":"Vicentini","year":"2022","journal-title":"Antibiotics"},{"key":"2026021205170614200_jfaf144-B3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1542\/pir.2018-0016","article-title":"Mycoplasma pneumonia in children and adolescents","volume":"41","author":"Krafft","year":"2020","journal-title":"Pediatr Rev"},{"key":"2026021205170614200_jfaf144-B4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11908-000-0023-y","article-title":"The role of Chlamydia in upper respiratory tract infections","volume":"2","author":"Hammerschlag","year":"2000","journal-title":"Curr Infect Dis Rep"},{"key":"2026021205170614200_jfaf144-B5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jemermed.2008.04.048","article-title":"Prevalence of Bordetella pertussis and Bordetella parapertussis in infants presenting to the emergency department with bronchiolitis","volume":"40","author":"Walsh","year":"2011","journal-title":"J Emerg Med"},{"key":"2026021205170614200_jfaf144-B6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1542\/peds.2004-0670","article-title":"Provider and practice characteristics associated with antibiotic use in children with presumed viral respiratory tract infections","volume":"115","author":"Gaur","year":"2005","journal-title":"Pediatrics"},{"key":"2026021205170614200_jfaf144-B7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1542\/peds.2011-1337","article-title":"Antibiotic prescribing in ambulatory pediatrics in the United States","volume":"128","author":"Hersh","year":"2011","journal-title":"Pediatrics"},{"key":"2026021205170614200_jfaf144-B8","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1345\/aph.1G717","article-title":"Systematic review of medication errors in pediatric patients","volume":"40","author":"Ghaleb","year":"2006","journal-title":"Ann Pharmacother"},{"key":"2026021205170614200_jfaf144-B9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1542\/peds.2009-1527","article-title":"Previous antimicrobial exposure is associated with drug-resistant urinary tract infections in children","volume":"125","author":"Paschke","year":"2010","journal-title":"Pediatrics"},{"key":"2026021205170614200_jfaf144-B10","doi-asserted-by":"crossref","first-page":"e0006622","DOI":"10.1128\/jcm.00066-22","article-title":"Multicenter evaluation of the BioFire respiratory panel 2.1 (RP2.1) for detection of SARS-CoV-2 in nasopharyngeal swab samples","volume":"60","author":"Berry","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2026021205170614200_jfaf144-B11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/diagnostics13010034","article-title":"Rapid evaluation of the Xpert((R)) Xpress CoV-2 plus and Xpert((R)) Xpress CoV-2\/Flu\/RSV plus tests","volume":"13","author":"Noble","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026021205170614200_jfaf144-B12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcv.2019.104232","article-title":"Performance evaluation of the Panther Fusion(R) respiratory tract panel","volume":"123","author":"Voermans","year":"2020","journal-title":"J Clin Virol"},{"key":"2026021205170614200_jfaf144-B13","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.02090-10","article-title":"Comparison of the Luminex xTAG respiratory viral panel with xTAG respiratory viral panel fast for diagnosis of respiratory virus infections","volume":"49","author":"Pabbaraju","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2026021205170614200_jfaf144-B14"},{"key":"2026021205170614200_jfaf144-B15","author":"Centers for Disease Control and Prevention"},{"key":"2026021205170614200_jfaf144-B16","doi-asserted-by":"crossref","first-page":"piae119","DOI":"10.1093\/jpids\/piae119","article-title":"Resurgence of pediatric Mycoplasma pneumoniae infections in southeast Texas, November 2023-June 2024","volume":"14","author":"Danner","year":"2025","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2026021205170614200_jfaf144-B17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cll.2020.08.001","article-title":"Panels and syndromic testing in clinical microbiology","volume":"40","author":"Dien Bard","year":"2020","journal-title":"Clin Lab Med"},{"key":"2026021205170614200_jfaf144-B18","doi-asserted-by":"crossref","first-page":"000332","DOI":"10.1099\/acmi.0.000332","article-title":"A retrospective study examining the clinical significance of testing respiratory panels in children who presented to a tertiary hospital in 2019","volume":"4","author":"Almannaei","year":"2022","journal-title":"Access Microbiol"},{"key":"2026021205170614200_jfaf144-B19","doi-asserted-by":"crossref","first-page":"e0111624","DOI":"10.1128\/spectrum.01116-24","article-title":"Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023\/2024 respiratory viral season","volume":"12","author":"Mostafa","year":"2024","journal-title":"Microbiol Spectr"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/1\/113\/65019950\/jfaf144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/1\/113\/65019950\/jfaf144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:17:14Z","timestamp":1770891434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/11\/1\/113\/8305577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,29]]},"published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfaf144","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,10,29]]}}}